Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
1. 请及时下载文件确认是否正确, 系统将在 2025-06-11 15:59:12 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jaad.2024.09.031
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0190962224028871
其他信息:
出版社: Elsevier BV
作者: Kexiang Yan; Fuqiu Li; Xiaodong Bi; Ling Han; Zhenghua Zhang; Rixin Chen; Yuye Li; Litao Zhang; Xiaohua Wang; Linfeng Li; Jianyun Lu; Ai'e Xu; Sen Yang; Yan Lu; Jianfang Sun; Zhiming Li; Xiaohong Zhu; Meiying Jiang; Siping Zhang; Wenqing Wang; Yanling Li; Zudong Meng; Hongyi Li; Kuanhou Mou; Xiuping Han; Shanshan Li; Aijun Chen; Xin Li; Donghua Liu; Chunlei Zhang; Chao Ji; Yu Wang; Hao Cheng; Xiaojing Cui; Xiaoyan Yao; Xiaoyan Bai; Guangchao Dong; Jinhua Xu
